Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Dunn

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|January 28, 2003
Mining the human "kinome"David A Dunn
Journal of Biomedicine & Biotechnology|July 11, 2012
Nuclear expression of a mitochondrial DNA gene: mitochondrial targeting of allotopically expressed mutant ATP6 in transgenic miceDavid A Dunn, Carl A Pinkert
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2021
Allotopic Expression of ATP6 in Mouse as a Transgenic Model of Mitochondrial DiseaseDavid A Dunn, Carl A Pinkert
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2015
Allotopic expression of ATP6 in the mouse as a transgenic model of mitochondrial diseaseDavid A Dunn, Carl A Pinkert
Drug Discovery Today|June 1, 2005
Foundation Review: Transgenic animals and their impact on the drug discovery industryDavid A Dunn, Carl A Pinkert, David L Kooyman
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 15, 2013
Biomimetic materials design for cardiac tissue regenerationDavid A Dunn, Alexander J Hodge, Elizabeth A Lipke
Current Pharmaceutical Biotechnology|September 3, 2010
Taking a systems approach to the identification of novel therapeutic targets and biomarkersDavid A Dunn, Donald Apanovitch, Max Follettie, et al.
Assay and Drug Development Technologies|May 29, 2004
Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassaysJames R Beasley, Paul M McCoy, Tiffany L Walker, et al.
Biochimica Et Biophysica Acta|August 23, 2011
Animal models of human mitochondrial DNA mutationsDavid A Dunn, Matthew V Cannon, Michael H Irwin, et al.
Assay and Drug Development Technologies|April 20, 2004
1,536-well assay development and screening using whole cell displacement binding and laser scanning imagingDouglas S Auld, David A Dunn, John M Lehrach, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|January 28, 2003
Mining the human "kinome"David A Dunn
Journal of Biomedicine & Biotechnology|July 11, 2012
Nuclear expression of a mitochondrial DNA gene: mitochondrial targeting of allotopically expressed mutant ATP6 in transgenic miceDavid A Dunn, Carl A Pinkert
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2021
Allotopic Expression of ATP6 in Mouse as a Transgenic Model of Mitochondrial DiseaseDavid A Dunn, Carl A Pinkert
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2015
Allotopic expression of ATP6 in the mouse as a transgenic model of mitochondrial diseaseDavid A Dunn, Carl A Pinkert
Drug Discovery Today|June 1, 2005
Foundation Review: Transgenic animals and their impact on the drug discovery industryDavid A Dunn, Carl A Pinkert, David L Kooyman
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 15, 2013
Biomimetic materials design for cardiac tissue regenerationDavid A Dunn, Alexander J Hodge, Elizabeth A Lipke
Current Pharmaceutical Biotechnology|September 3, 2010
Taking a systems approach to the identification of novel therapeutic targets and biomarkersDavid A Dunn, Donald Apanovitch, Max Follettie, et al.
Assay and Drug Development Technologies|May 29, 2004
Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassaysJames R Beasley, Paul M McCoy, Tiffany L Walker, et al.
Biochimica Et Biophysica Acta|August 23, 2011
Animal models of human mitochondrial DNA mutationsDavid A Dunn, Matthew V Cannon, Michael H Irwin, et al.
Assay and Drug Development Technologies|April 20, 2004
1,536-well assay development and screening using whole cell displacement binding and laser scanning imagingDouglas S Auld, David A Dunn, John M Lehrach, et al.
Pageof 2